(Q40183748)

18 September 2017

title

Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases? (English)

1 reference

Nodular regenerative hyperplasia

18 September 2017

1 reference

1 reference

2

1 reference

18 September 2017

Catherine Hubert

1

1 reference

18 September 2017

Yves Horsmans

3

1 reference

18 September 2017

Jacques Rahier

4

1 reference

18 September 2017

Yves Humblet

5

1 reference

18 September 2017

Jean-Pascal Machiels

6

1 reference

18 September 2017

Antonino Ceratti

7

1 reference

18 September 2017

Jean-Luc Canon

8

1 reference

18 September 2017

Jean-François Gigot

9

1 reference

18 September 2017

publication date

1 September 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

27

1 reference

18 September 2017

issue

7

1 reference

18 September 2017

page(s)

938-943

1 reference

Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Histopathology of portal hypertension: a practical guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Noncirrhotic portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Benign focal lesions of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Oxaliplatin toxicity masquerading as recurrent colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Portal vein embolization: rationale, technique and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2007.01511.X

10.1111/J.1478-3231.2007.01511.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference